Cotización Praxis Precision Medicines - PRAX

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

71.76

Postura de Compra

40.00

Postura de Venta

249.50

Volume Operado de la Acción

550,140

69.54 Rango del Día 76.57

13.50 Rango de 52 semanas 86.93

Capitalización de Mercado [m]

9.225B

Precio Anterior

76.88

Precio de Apertura

76.57

Hora

1445

71.76

(formt)

Última hora de negociación

Volumen financiero

US$ 39,210,343

Precio Promedio Ponderado

71.2734

Volumen promedio (3 m)

284,707

Acciones en circulación

128,550,000

Rendimiento del Dividendo

Ratio Precio/Utilidad

-75.05

Beneficio por acción (BPA)

-0.96

turnover

2.45M

Beneficio neto

-123.28M

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, fo... Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.praxismedicines.com

Sede

Wilmington, Delaware, USA

Fundado

Praxis Precision Medicines Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PRAX. The last closing price for Praxis Precision Medicines was US$76.88. Over the last year, Praxis Precision Medicines shares have traded in a share price range of US$ 13.50 to US$ 86.93.

Praxis Precision Medicines currently has 128,550,000 shares in issue. The market capitalisation of Praxis Precision Medicines is US$9.88 billion. Praxis Precision Medicines has a price to earnings ratio (PE ratio) of -75.05.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-3.52	-4.67587672689	75.28	86.93	71.76	361371	81.40994351	CS
4	-3.35	-4.46012514978	75.11	86.93	58.835	298397	74.85174576	CS
12	21.77	43.5487097419	49.99	86.93	48.22	284707	66.08710603	CS
26	24.49	51.8087581976	47.27	86.93	33.01	324033	54.03235323	CS
52	58.26	431.555555556	13.5	86.93	13.5	266481	49.37501428	CS
156	-233.19	-76.4682734875	304.95	312.75	11.85	773858	42.37820471	CS
260	-336.39	-82.4182285924	408.15	914.2575	11.85	640688	85.41025932	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.15B
CYCNCyclerion Therapeutics Inc	US$ 2.5306 (42.97%)	11.99M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	164.49M
PULMPulmatrix Inc	US$ 6.5586 (39.54%)	5.31M
ZTEKZentek Ltd	US$ 1.2574 (29.96%)	308.63k
TFFPTFF Pharmaceuticals Inc	US$ 0.376101 (-76.49%)	9.35M
EYENEyenovia Inc	US$ 0.10185 (-70.05%)	52.8M
CTXRCitius Pharmaceuticals Inc	US$ 0.1974 (-39.89%)	11.26M
VVPRVivoPower International PLC	US$ 0.8151 (-39.62%)	2.34M
IPWiPower Inc	US$ 0.7302 (-39.15%)	1.15M
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.17B
ELABElevai Labs Inc	US$ 0.0211 (-19.47%)	380.03M
NVDANVIDIA Corporation	US$ 141.98 (-3.26%)	253.02M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	165.69M
STISolidion Technology Inc	US$ 0.44 (25.71%)	140.02M